Search / Trial NCT06230770

Impact of Progestin-only Contraception on Bleeding Patterns in Individuals Initiating GATT

Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jan 19, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Progestin Testosterone Gender Affirming Bleeding

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * English-speaking currently have a uterus and ovaries
  • * desire to initiate GATT
  • * potential desire to initiate a progestin (within 14 days of GATT initiation)
  • Exclusion Criteria:
  • * previous gender-affirming surgery to remove their uterus and/or ovaries

About University Of California, San Diego

The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.

Locations

San Diego, California, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0